Sentynl Therapeutics, Inc.
Matt Heck is the Founder & CEO of Sentynl Therapeutics, Inc. Matt previously co-founded Victory Pharma and held the position of Co-founder & CEO. Matt's experience also includes being the Vice President of Sales at Biovail Pharmaceuticals and DJ Pharma, Inc. Prior to this, Matt held various roles at Dura Pharmaceuticals Inc. Matt Heck attended the University of South Carolina Darla Moore School of Business where Matt obtained a Bachelor's degree in Marketing.
Sentynl Therapeutics, Inc.
Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.